Imaging for Postmenopausal Bleeding
Transvaginal ultrasound (TVUS) combined with transabdominal ultrasound is the first-line imaging modality for evaluating postmenopausal bleeding, with an endometrial thickness ≤4 mm having a nearly 100% negative predictive value for endometrial cancer. 1
Initial Imaging Approach
The imaging workup should proceed algorithmically based on TVUS findings:
Primary Screening: Transvaginal Ultrasound
- TVUS combined with transabdominal approach is the standard initial imaging 1
- The transabdominal component is essential when the uterus is enlarged or when TVUS has limited field of view 1
- Color Doppler should be incorporated as a standard component to evaluate endometrial vascularity 1
Critical Threshold: Endometrial Thickness
The 4-5 mm endometrial thickness threshold is the key decision point:
- Endometrium <4 mm: Nearly 100% negative predictive value for cancer; no further imaging needed unless bleeding persists 1, 2
- Endometrium ≥5 mm: Proceed to endometrial tissue sampling 1
- Note that TVUS cannot reliably determine the etiology of endometrial thickening, only its presence 1
When Initial TVUS is Inconclusive or Shows Focal Abnormality
Saline Infusion Sonohysterography (SIS)
If TVUS demonstrates a focal endometrial abnormality or thickened endometrium, sonohysterography is the next appropriate step 1:
- Uses transcervical injection of sterile saline (not gel) as the standard contrast agent 1
- Achieves 97% pooled accuracy in distinguishing leiomyomas from endometrial polyps 1
- Critical limitation: Cannot reliably distinguish benign endometrial pathology from endometrial cancer, so endometrial sampling or hysteroscopy remains necessary 1
MRI Pelvis
MRI with gadolinium-based IV contrast and diffusion-weighted imaging should be considered when:
- Ultrasound cannot adequately visualize the endometrium (due to patient body habitus, uterine position, or coexisting pathology like leiomyomas/adenomyosis) 1
- Further characterization is needed after inconclusive ultrasound 1
MRI performance characteristics 1:
- Sensitivity/specificity for endometrial cancer: 79%/89%
- Sensitivity/specificity for leiomyosarcoma: 100%/100%
- Diffusion-weighted imaging improves differentiation of benign from malignant pathology 1
What NOT to Use
CT pelvis has no role in the evaluation of postmenopausal bleeding 1. There is no literature supporting its use for initial assessment or follow-up imaging of abnormal uterine bleeding.
Follow-Up Imaging
If initial imaging and clinical evaluation are negative, endometrial cancer is extremely unlikely 1. However:
- Repeat TVUS can be performed if bleeding persists, as endometrial cancers may be missed on initial imaging 1
- If endometrium remains <4 mm on repeat imaging, the negative predictive value for cancer remains nearly 100% 1
Common Pitfalls to Avoid
Don't rely on TVUS alone when visualization is incomplete: Patient body habitus, uterine position, and presence of leiomyomas/adenomyosis can limit visualization 1. In these cases, proceed directly to MRI or endometrial sampling based on cancer risk factors 1
Don't assume sonohysterography can exclude malignancy: Despite its excellent ability to characterize focal lesions, it cannot reliably distinguish benign from malignant endometrial pathology 1
Don't forget the transabdominal component: A combined approach is necessary for complete pelvic assessment, particularly with enlarged uteri 1
Don't use endometrial thickness cutoffs from premenopausal women: The 4-5 mm threshold is specific to postmenopausal women; premenopausal endometrial thickness varies with menstrual cycle and has no validated upper limit 1
Integration with Tissue Diagnosis
While imaging guides the workup, endometrial sampling or hysteroscopy remains necessary when:
- Endometrial thickness >4 mm 1
- Any focal endometrial abnormality is identified 1
- Bleeding persists despite reassuring imaging 1
- Patient has risk factors for endometrial cancer regardless of imaging findings 1
The imaging algorithm serves primarily to triage patients and identify those who can safely avoid invasive procedures versus those requiring tissue diagnosis 2, 3.